FDA: Mifepristone review won't be done until March

Source: thehill.com · Section: politics · Bias: Center · Published: Thu, 08 Oct 2026 02:33:30 GMT

The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion activists, who have been losing patience with the...

Read the full article at thehill.com →

The same story across the political spectrum (15 sources)

Left: Trump administration paving way for temporary sale of some unapproved peptides — www.washingtonpost.com
Left: Mother accused of stabbing her young children — 1 of them just 10 months old — and her husband — www.theblaze.com
Left: Exclusive: Paxton privately blames campaign woes on Iran war, gas prices — www.axios.com
Center: FDA says it will complete safety review of abortion pill in March — www.nbcnews.com
Center-Right: Why France is a warning sign for the markets — www.axios.com
Center: Trump's midterm strategists draw scrutiny over Russia-aligned work — www.axios.com
Right: 'The panic is palpable': El-Sayed facing opposition from key Michigan Democrat groups weeks before election — www.theblaze.com
Right: Teen wannabe ISIS terrorist plotted to slaughter dozens of non-Muslims at Mall of America, FBI says — www.theblaze.com
Right: Raskin seeks to preserve Trump's D.C. "propaganda" in Smithsonian — www.axios.com
Right: DNC sues to stop Trump's taxpayer-funded ad blitz — www.axios.com

← Back to FlashTopics.com